Review Articles
Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity
Authors:
- Monica Samuel AvilaEmail Monica Samuel Avila
- Suellen Rodrigues Rangel Siqueira
- Silvia Moreira Ayub Ferreira
- Edimar Alcides Bocchi
Abstract
Recent decades have seen an increase in survival rates for cancer patients, partially explained by earlier diagnoses and new chemotherapeutic agents. However, chemotherapy may be associated with adverse cardiovascular events, including hypertension and pulmonary hypertension, supraventricular and ventricular arrhythmias, cardiomyopathy, and other forms of cardiovascular disease. For patients, the benefits of chemotherapy may be partially obfuscated by deleterious effects on the cardiovascular system, resulting in a significant increase in morbidity and mortality. In this article, we review strategies for prevention and treatment of chemotherapy-related cardiotoxicity.
- Year: 2019
- Volume: 15 Issue: 4
- Page/Article: 267-273
- DOI: 10.14797/mdcj-15-4-267
- Published on 1 Oct 2019
- Peer Reviewed